Navigation Links
Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
Date:3/30/2009

The FDA regulatory filing for Afinitor was based on data from RECORD-1 (REnal Cell cancer treatment with Oral RAD001 given Daily), the largest Phase III clinical trial to study the effects of an oral mTOR inhibitor in advanced RCC patients whose cancer progressed despite prior treatment with sunitinib, sorafenib or both sequentially. In February 2008, based on a recommendation from an independent data monitoring committee, Novartis stopped the trial after interim results showed that patients receiving Afinitor experienced a significant delay in cancer progressing or death compared with patients receiving placebo(1).

This international, multi-center, randomized, double-blind trial involved 416 patients with advanced RCC whose cancer progressed despite prior treatment with sunitinib, sorafenib or both sequentially. In addition, prior therapy with bevacizumab, interferon alfa and interleukin-2 was allowed. Patients were randomized to receive Afinitor (10 mg) daily or placebo, in conjunction with best supportive care. The primary endpoint of the study was progression-free survival, which was assessed via a blinded independent, central radiological review(10).

About Afinitor

Afinitor is the first oral, daily therapy (5 mg and 10 mg tablets) to treat advanced kidney cancer after failure of treatment with sunitinib or sorafenib. In cancer cells, Afinitor continuously targets mTOR, a protein that acts as a central regulator of tumor cell division, blood vessel growth and cell metabolism. Afinitor is also being studied in multiple cancer types, including neuroendocrine, breast, gastric and hepatocellular carcinoma (HCC), as well as tuberous sclerosis complex (TSC) and non-Hodgkin's lymphoma(11).

The active ingredient in Afinitor is everolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013  Sinovac Biotech Ltd. (NASDAQ: ... in China , announced that ... Sinovac, obtained the Certificate of Good Manufacturing Practices ... State and Food Administration (CFDA) for its proprietary ... its Changping filing and packaging facility. The GMP ...
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
(Date:5/23/2013)... May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... named the 2013 Life Science Firm of the Year by ... Vanda was honored at the TCM,s 25 th Annual ... Maryland.  The Tech Awards Celebration recognizes the leaders and innovators ... Maryland and the surrounding regions. ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... Fla. , June 1 ... available in a convenient two-ounce pouch as the LIMU ... products, launched the new packaging as a part of ... Fucoidan products into the marketplace, focusing on the marine ...
... 1 Cardiogenesis Corporation (Pink Sheets: CGCP), today announced that ... Equity Conference - ONTRACK 2010 to be held at the Hard ... J. McCormick will present a 30-minute corporate overview on ... ( 2:00 pm Pacific Time ) and meet one-on-one with ...
Cached Medicine Technology:Get the Leading Fucoidan Supplement on the go With LIMU ORIGINAL(TM) SHOT 2Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010 2
(Date:5/24/2013)... May 24, 2013 KC and Monica Craichy, ... Sponsors for FreeRide836. Their oldest sons, Kyle and Austin Craichy, ... Russell family and several professional kiteboarders. , KC Craichy said ... "This has miraculously come together such that virtually everyone who ... participate." , 20 kite boarders will meet at Matheson Hammock ...
(Date:5/24/2013)... E-Dentists.com has announced the launch of their new ... a leading medical Internet marketing agency. , ... focus on providing dentists the help they need to ... keywords. The dental SEO analysis covers a full analysis ... their competitors are doing right. The goal is to ...
(Date:5/24/2013)... May 24, 2013 Started in 1982, AMTC’s ... in Orlando. 2013 marks AMTC’s 31st anniversary. SHINE is a ... with supermodel Millie Lewis and her daughter, Carey Lewis Arban. ... managers, casting directors, and music professionals including the New York ... XP Media. They are kings of Hollywood and Christian casting ...
(Date:5/24/2013)... 24, 2013 Amirsys today announces the ... enhancements for instructors and students. Instructors can use the ... personalize learning plan templates, targeted reading assignments, and customized ... new assessment questions, 5,000 searchable anatomy glossary terms, and ... AnatomyOne 2.0 is the first gross anatomy resource ...
(Date:5/24/2013)... 2013 Dwell Media LLC ... as Executive Vice President of Digital for Dwell Media. ... represented a large portion of Yahoo's global media business. ... develops a fully-integrated commerce unit to launch in 2014. ... digital content for leading firms in Silicon Valley. Dwell, ...
Breaking Medicine News(10 mins):Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2
... While the holidays tend to translate into restaurant meals that ... home, eating out doesn,t have to be unhealthy, an expert ... from consuming hundreds of extra calories. "The average American ... outside of the home and fast-food restaurants are abundant," said ...
... or more of the adverse complications of obesity, including type ... drugs designed to treat obesity have shown limited efficacy and ... because we have limited understanding of the effects of obesity ... while great strides have been made in our understanding of ...
... TUESDAY, Dec. 27 (HealthDay News) -- No doubt about it. ... elicit a wide range of emotional responses by their very ... animals are being involved in human therapy in innovative ways ... "Most people think of nursing homes, and people going in ...
... , MONDAY, Dec. 26 (HealthDay News) -- Teens ... poor emotional relationship with their mother when they were toddlers, ... research showing that toddlers who didn,t have close emotional ties ... the time they were 4.5 years old. In the ...
... An advisory from two leading allergists, Robert Wood of the ... Hospital in New York, urges clinicians to use caution when ... solely on test results. In an article, published ... warn that blood tests, an increasingly popular diagnostic tool in ...
... , FRIDAY, Dec. 23 (HealthDay News) -- A new ... personal health records with others, a finding that surprised ... their caregivers and health care providers to access their ... care," said first author Dr. Donna Zulman, an instructor ...
Cached Medicine News:Health News:Eating Out Doesn't Have to Mean Excess Calories 2Health News:The New Face of Pet Therapy 2Health News:The New Face of Pet Therapy 3Health News:Mother-Toddler Bond May Influence Teen Obesity 2Health News:Memo to pediatricians: Allergy tests are no magic bullets for diagnosis 2Health News:Memo to pediatricians: Allergy tests are no magic bullets for diagnosis 3Health News:Many VA Patients Would Share Personal Health Records, Study Finds 2
... patient care reports for cardiology and ... reporting and documentation tool, physicians can ... H&P, labs, medications, and procedural details. ... with an e-signature, and distributed at ...
... The worlds most accurate ultrasonic technology. ... refractive surgery you will want to use ... comes from a combination of analog and ... different way than all the other ultrasonic ...
...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
Medicine Products: